Package 47781-335-30

Brand: pyridostigmine bromide

Generic: pyridostigmine bromide
NDC Package

Package Facts

Identity

Package NDC 47781-335-30
Digits Only 4778133530
Product NDC 47781-335
Product ID 47781-335_0429e410-7623-2f45-6170-d4a2eadd8742
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-335-30)

Marketing

Marketing Status
Marketed Since 2015-06-29
Brand pyridostigmine bromide
Generic pyridostigmine bromide
Sample Package No

Linked Drug Pages (1)

Pyridostigmine Bromide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0429e410-7623-2f45-6170-d4a2eadd8742", "openfda": {"upc": ["0347781335304"], "unii": ["KVI301NA53"], "rxcui": ["903847"], "spl_set_id": ["93454159-0c58-1980-34b9-4038a2260420"], "manufacturer_name": ["Alvogen, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-335-30)", "package_ndc": "47781-335-30", "marketing_start_date": "20150629"}], "brand_name": "Pyridostigmine Bromide", "product_id": "47781-335_0429e410-7623-2f45-6170-d4a2eadd8742", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "47781-335", "generic_name": "Pyridostigmine Bromide", "labeler_name": "Alvogen, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "180 mg/1"}], "application_number": "ANDA204737", "marketing_category": "ANDA", "marketing_start_date": "20150629", "listing_expiration_date": "20261231"}